世界の子宮摘出術代替案市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hysterectomy Alternatives Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5202
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、子宮摘出術代替案の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（筋腫摘出術、子宮動脈塞栓術（UAE）、子宮鏡検査、子宮内膜アブレーション、ホルモン療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・子宮摘出術代替案の市場動向
・企業の競争状況、市場シェア
・子宮摘出術代替案の種類別市場規模と予測2016-2027（筋腫摘出術、子宮動脈塞栓術（UAE）、子宮鏡検査、子宮内膜アブレーション、ホルモン療法）
・子宮摘出術代替案の用途別市場規模と予測2016-2027（病院、診療所、その他）
・子宮摘出術代替案の北米市場規模2016-2027（アメリカ、カナダ）
・子宮摘出術代替案の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・子宮摘出術代替案のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・子宮摘出術代替案の中南米市場規模2016-2027（メキシコ、ブラジル）
・子宮摘出術代替案の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Conceptus Inc.、Johnson & Johnson(Ethicon Inc.)、Hologic Inc.、Boston Scientific Corporation、Karl Storz SE & Co. KG、Cooper Companies, Inc.(Coopersurgical Inc.)、Planmeca (PLANMED OY)、Agfa-Gevaert Group、Gynecare）
・結論

Hysterectomy alternatives are alternative methods that are being adopted to overcome the side-effects associated with Hysterectomy, which is performed when a woman is suffering from conditions such as fibroids and uterine prolapse.

Market Analysis and Insights: Global Hysterectomy Alternatives Market
The global Hysterectomy Alternatives market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hysterectomy Alternatives market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hysterectomy Alternatives market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hysterectomy Alternatives market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hysterectomy Alternatives market.

Global Hysterectomy Alternatives Scope and Market Size
Hysterectomy Alternatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hysterectomy Alternatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Procedure Type
Myomectomy
Uterine Artery Embolization (UAE)
Hysteroscopy
Endometrial Ablation
Hormonal Treatments
by Type
Invasive
Non-Invasive

Segment by Application
Hospitals
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Conceptus Inc.
Johnson & Johnson(Ethicon Inc.)
Hologic Inc.
Boston Scientific Corporation
Karl Storz SE & Co. KG
Cooper Companies, Inc.(Coopersurgical Inc.)
Planmeca (PLANMED OY)
Agfa-Gevaert Group
Gynecare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hysterectomy Alternatives Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Myomectomy
1.2.3 Uterine Artery Embolization (UAE)
1.2.4 Hysteroscopy
1.2.5 Endometrial Ablation
1.2.6 Hormonal Treatments
1.3 Market by Application
1.3.1 Global Hysterectomy Alternatives Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hysterectomy Alternatives Market Perspective (2016-2027)
2.2 Hysterectomy Alternatives Growth Trends by Regions
2.2.1 Hysterectomy Alternatives Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hysterectomy Alternatives Historic Market Share by Regions (2016-2021)
2.2.3 Hysterectomy Alternatives Forecasted Market Size by Regions (2022-2027)
2.3 Hysterectomy Alternatives Industry Dynamic
2.3.1 Hysterectomy Alternatives Market Trends
2.3.2 Hysterectomy Alternatives Market Drivers
2.3.3 Hysterectomy Alternatives Market Challenges
2.3.4 Hysterectomy Alternatives Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hysterectomy Alternatives Players by Revenue
3.1.1 Global Top Hysterectomy Alternatives Players by Revenue (2016-2021)
3.1.2 Global Hysterectomy Alternatives Revenue Market Share by Players (2016-2021)
3.2 Global Hysterectomy Alternatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hysterectomy Alternatives Revenue
3.4 Global Hysterectomy Alternatives Market Concentration Ratio
3.4.1 Global Hysterectomy Alternatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hysterectomy Alternatives Revenue in 2020
3.5 Hysterectomy Alternatives Key Players Head office and Area Served
3.6 Key Players Hysterectomy Alternatives Product Solution and Service
3.7 Date of Enter into Hysterectomy Alternatives Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hysterectomy Alternatives Breakdown Data by Type
4.1 Global Hysterectomy Alternatives Historic Market Size by Type (2016-2021)
4.2 Global Hysterectomy Alternatives Forecasted Market Size by Type (2022-2027)

5 Hysterectomy Alternatives Breakdown Data by Application
5.1 Global Hysterectomy Alternatives Historic Market Size by Application (2016-2021)
5.2 Global Hysterectomy Alternatives Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hysterectomy Alternatives Market Size (2016-2027)
6.2 North America Hysterectomy Alternatives Market Size by Type
6.2.1 North America Hysterectomy Alternatives Market Size by Type (2016-2021)
6.2.2 North America Hysterectomy Alternatives Market Size by Type (2022-2027)
6.2.3 North America Hysterectomy Alternatives Market Size by Type (2016-2027)
6.3 North America Hysterectomy Alternatives Market Size by Application
6.3.1 North America Hysterectomy Alternatives Market Size by Application (2016-2021)
6.3.2 North America Hysterectomy Alternatives Market Size by Application (2022-2027)
6.3.3 North America Hysterectomy Alternatives Market Size by Application (2016-2027)
6.4 North America Hysterectomy Alternatives Market Size by Country
6.4.1 North America Hysterectomy Alternatives Market Size by Country (2016-2021)
6.4.2 North America Hysterectomy Alternatives Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hysterectomy Alternatives Market Size (2016-2027)
7.2 Europe Hysterectomy Alternatives Market Size by Type
7.2.1 Europe Hysterectomy Alternatives Market Size by Type (2016-2021)
7.2.2 Europe Hysterectomy Alternatives Market Size by Type (2022-2027)
7.2.3 Europe Hysterectomy Alternatives Market Size by Type (2016-2027)
7.3 Europe Hysterectomy Alternatives Market Size by Application
7.3.1 Europe Hysterectomy Alternatives Market Size by Application (2016-2021)
7.3.2 Europe Hysterectomy Alternatives Market Size by Application (2022-2027)
7.3.3 Europe Hysterectomy Alternatives Market Size by Application (2016-2027)
7.4 Europe Hysterectomy Alternatives Market Size by Country
7.4.1 Europe Hysterectomy Alternatives Market Size by Country (2016-2021)
7.4.2 Europe Hysterectomy Alternatives Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hysterectomy Alternatives Market Size (2016-2027)
8.2 Asia-Pacific Hysterectomy Alternatives Market Size by Type
8.2.1 Asia-Pacific Hysterectomy Alternatives Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hysterectomy Alternatives Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hysterectomy Alternatives Market Size by Type (2016-2027)
8.3 Asia-Pacific Hysterectomy Alternatives Market Size by Application
8.3.1 Asia-Pacific Hysterectomy Alternatives Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hysterectomy Alternatives Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hysterectomy Alternatives Market Size by Application (2016-2027)
8.4 Asia-Pacific Hysterectomy Alternatives Market Size by Region
8.4.1 Asia-Pacific Hysterectomy Alternatives Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hysterectomy Alternatives Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hysterectomy Alternatives Market Size (2016-2027)
9.2 Latin America Hysterectomy Alternatives Market Size by Type
9.2.1 Latin America Hysterectomy Alternatives Market Size by Type (2016-2021)
9.2.2 Latin America Hysterectomy Alternatives Market Size by Type (2022-2027)
9.2.3 Latin America Hysterectomy Alternatives Market Size by Type (2016-2027)
9.3 Latin America Hysterectomy Alternatives Market Size by Application
9.3.1 Latin America Hysterectomy Alternatives Market Size by Application (2016-2021)
9.3.2 Latin America Hysterectomy Alternatives Market Size by Application (2022-2027)
9.3.3 Latin America Hysterectomy Alternatives Market Size by Application (2016-2027)
9.4 Latin America Hysterectomy Alternatives Market Size by Country
9.4.1 Latin America Hysterectomy Alternatives Market Size by Country (2016-2021)
9.4.2 Latin America Hysterectomy Alternatives Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hysterectomy Alternatives Market Size (2016-2027)
10.2 Middle East & Africa Hysterectomy Alternatives Market Size by Type
10.2.1 Middle East & Africa Hysterectomy Alternatives Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hysterectomy Alternatives Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hysterectomy Alternatives Market Size by Type (2016-2027)
10.3 Middle East & Africa Hysterectomy Alternatives Market Size by Application
10.3.1 Middle East & Africa Hysterectomy Alternatives Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hysterectomy Alternatives Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hysterectomy Alternatives Market Size by Application (2016-2027)
10.4 Middle East & Africa Hysterectomy Alternatives Market Size by Country
10.4.1 Middle East & Africa Hysterectomy Alternatives Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hysterectomy Alternatives Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Conceptus Inc.
11.1.1 Conceptus Inc. Company Details
11.1.2 Conceptus Inc. Business Overview
11.1.3 Conceptus Inc. Hysterectomy Alternatives Introduction
11.1.4 Conceptus Inc. Revenue in Hysterectomy Alternatives Business (2016-2021)
11.1.5 Conceptus Inc. Recent Development
11.2 Johnson & Johnson(Ethicon Inc.)
11.2.1 Johnson & Johnson(Ethicon Inc.) Company Details
11.2.2 Johnson & Johnson(Ethicon Inc.) Business Overview
11.2.3 Johnson & Johnson(Ethicon Inc.) Hysterectomy Alternatives Introduction
11.2.4 Johnson & Johnson(Ethicon Inc.) Revenue in Hysterectomy Alternatives Business (2016-2021)
11.2.5 Johnson & Johnson(Ethicon Inc.) Recent Development
11.3 Hologic Inc.
11.3.1 Hologic Inc. Company Details
11.3.2 Hologic Inc. Business Overview
11.3.3 Hologic Inc. Hysterectomy Alternatives Introduction
11.3.4 Hologic Inc. Revenue in Hysterectomy Alternatives Business (2016-2021)
11.3.5 Hologic Inc. Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Hysterectomy Alternatives Introduction
11.4.4 Boston Scientific Corporation Revenue in Hysterectomy Alternatives Business (2016-2021)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Karl Storz SE & Co. KG
11.5.1 Karl Storz SE & Co. KG Company Details
11.5.2 Karl Storz SE & Co. KG Business Overview
11.5.3 Karl Storz SE & Co. KG Hysterectomy Alternatives Introduction
11.5.4 Karl Storz SE & Co. KG Revenue in Hysterectomy Alternatives Business (2016-2021)
11.5.5 Karl Storz SE & Co. KG Recent Development
11.6 Cooper Companies, Inc.(Coopersurgical Inc.)
11.6.1 Cooper Companies, Inc.(Coopersurgical Inc.) Company Details
11.6.2 Cooper Companies, Inc.(Coopersurgical Inc.) Business Overview
11.6.3 Cooper Companies, Inc.(Coopersurgical Inc.) Hysterectomy Alternatives Introduction
11.6.4 Cooper Companies, Inc.(Coopersurgical Inc.) Revenue in Hysterectomy Alternatives Business (2016-2021)
11.6.5 Cooper Companies, Inc.(Coopersurgical Inc.) Recent Development
11.7 Planmeca (PLANMED OY)
11.7.1 Planmeca (PLANMED OY) Company Details
11.7.2 Planmeca (PLANMED OY) Business Overview
11.7.3 Planmeca (PLANMED OY) Hysterectomy Alternatives Introduction
11.7.4 Planmeca (PLANMED OY) Revenue in Hysterectomy Alternatives Business (2016-2021)
11.7.5 Planmeca (PLANMED OY) Recent Development
11.8 Agfa-Gevaert Group
11.8.1 Agfa-Gevaert Group Company Details
11.8.2 Agfa-Gevaert Group Business Overview
11.8.3 Agfa-Gevaert Group Hysterectomy Alternatives Introduction
11.8.4 Agfa-Gevaert Group Revenue in Hysterectomy Alternatives Business (2016-2021)
11.8.5 Agfa-Gevaert Group Recent Development
11.9 Gynecare
11.9.1 Gynecare Company Details
11.9.2 Gynecare Business Overview
11.9.3 Gynecare Hysterectomy Alternatives Introduction
11.9.4 Gynecare Revenue in Hysterectomy Alternatives Business (2016-2021)
11.9.5 Gynecare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hysterectomy Alternatives Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Myomectomy
Table 3. Key Players of Uterine Artery Embolization (UAE)
Table 4. Key Players of Hysteroscopy
Table 5. Key Players of Endometrial Ablation
Table 6. Key Players of Hormonal Treatments
Table 7. Global Hysterectomy Alternatives Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hysterectomy Alternatives Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hysterectomy Alternatives Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hysterectomy Alternatives Market Share by Regions (2016-2021)
Table 11. Global Hysterectomy Alternatives Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hysterectomy Alternatives Market Share by Regions (2022-2027)
Table 13. Hysterectomy Alternatives Market Trends
Table 14. Hysterectomy Alternatives Market Drivers
Table 15. Hysterectomy Alternatives Market Challenges
Table 16. Hysterectomy Alternatives Market Restraints
Table 17. Global Hysterectomy Alternatives Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hysterectomy Alternatives Market Share by Players (2016-2021)
Table 19. Global Top Hysterectomy Alternatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hysterectomy Alternatives as of 2020)
Table 20. Ranking of Global Top Hysterectomy Alternatives Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hysterectomy Alternatives Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hysterectomy Alternatives Product Solution and Service
Table 24. Date of Enter into Hysterectomy Alternatives Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hysterectomy Alternatives Revenue Market Share by Type (2016-2021)
Table 28. Global Hysterectomy Alternatives Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hysterectomy Alternatives Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hysterectomy Alternatives Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hysterectomy Alternatives Revenue Market Share by Application (2016-2021)
Table 32. Global Hysterectomy Alternatives Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hysterectomy Alternatives Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hysterectomy Alternatives Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hysterectomy Alternatives Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hysterectomy Alternatives Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hysterectomy Alternatives Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hysterectomy Alternatives Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hysterectomy Alternatives Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hysterectomy Alternatives Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hysterectomy Alternatives Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hysterectomy Alternatives Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hysterectomy Alternatives Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hysterectomy Alternatives Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hysterectomy Alternatives Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hysterectomy Alternatives Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hysterectomy Alternatives Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hysterectomy Alternatives Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hysterectomy Alternatives Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hysterectomy Alternatives Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hysterectomy Alternatives Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hysterectomy Alternatives Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hysterectomy Alternatives Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hysterectomy Alternatives Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hysterectomy Alternatives Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hysterectomy Alternatives Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hysterectomy Alternatives Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hysterectomy Alternatives Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hysterectomy Alternatives Market Size by Country (2022-2027) & (US$ Million)
Table 64. Conceptus Inc. Company Details
Table 65. Conceptus Inc. Business Overview
Table 66. Conceptus Inc. Hysterectomy Alternatives Product
Table 67. Conceptus Inc. Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 68. Conceptus Inc. Recent Development
Table 69. Johnson & Johnson(Ethicon Inc.) Company Details
Table 70. Johnson & Johnson(Ethicon Inc.) Business Overview
Table 71. Johnson & Johnson(Ethicon Inc.) Hysterectomy Alternatives Product
Table 72. Johnson & Johnson(Ethicon Inc.) Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 73. Johnson & Johnson(Ethicon Inc.) Recent Development
Table 74. Hologic Inc. Company Details
Table 75. Hologic Inc. Business Overview
Table 76. Hologic Inc. Hysterectomy Alternatives Product
Table 77. Hologic Inc. Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 78. Hologic Inc. Recent Development
Table 79. Boston Scientific Corporation Company Details
Table 80. Boston Scientific Corporation Business Overview
Table 81. Boston Scientific Corporation Hysterectomy Alternatives Product
Table 82. Boston Scientific Corporation Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 83. Boston Scientific Corporation Recent Development
Table 84. Karl Storz SE & Co. KG Company Details
Table 85. Karl Storz SE & Co. KG Business Overview
Table 86. Karl Storz SE & Co. KG Hysterectomy Alternatives Product
Table 87. Karl Storz SE & Co. KG Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 88. Karl Storz SE & Co. KG Recent Development
Table 89. Cooper Companies, Inc.(Coopersurgical Inc.) Company Details
Table 90. Cooper Companies, Inc.(Coopersurgical Inc.) Business Overview
Table 91. Cooper Companies, Inc.(Coopersurgical Inc.) Hysterectomy Alternatives Product
Table 92. Cooper Companies, Inc.(Coopersurgical Inc.) Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 93. Cooper Companies, Inc.(Coopersurgical Inc.) Recent Development
Table 94. Planmeca (PLANMED OY) Company Details
Table 95. Planmeca (PLANMED OY) Business Overview
Table 96. Planmeca (PLANMED OY) Hysterectomy Alternatives Product
Table 97. Planmeca (PLANMED OY) Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 98. Planmeca (PLANMED OY) Recent Development
Table 99. Agfa-Gevaert Group Company Details
Table 100. Agfa-Gevaert Group Business Overview
Table 101. Agfa-Gevaert Group Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 102. Agfa-Gevaert Group Recent Development
Table 103. Gynecare Company Details
Table 104. Gynecare Business Overview
Table 105. Gynecare Hysterectomy Alternatives Product
Table 106. Gynecare Revenue in Hysterectomy Alternatives Business (2016-2021) & (US$ Million)
Table 107. Gynecare Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hysterectomy Alternatives Market Share by Type: 2020 VS 2027
Figure 2. Myomectomy Features
Figure 3. Uterine Artery Embolization (UAE) Features
Figure 4. Hysteroscopy Features
Figure 5. Endometrial Ablation Features
Figure 6. Hormonal Treatments Features
Figure 7. Global Hysterectomy Alternatives Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Hysterectomy Alternatives Report Years Considered
Figure 12. Global Hysterectomy Alternatives Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Hysterectomy Alternatives Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hysterectomy Alternatives Market Share by Regions: 2020 VS 2027
Figure 15. Global Hysterectomy Alternatives Market Share by Regions (2022-2027)
Figure 16. Global Hysterectomy Alternatives Market Share by Players in 2020
Figure 17. Global Top Hysterectomy Alternatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hysterectomy Alternatives as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Hysterectomy Alternatives Revenue in 2020
Figure 19. Global Hysterectomy Alternatives Revenue Market Share by Type (2016-2021)
Figure 20. Global Hysterectomy Alternatives Revenue Market Share by Type (2022-2027)
Figure 21. North America Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Hysterectomy Alternatives Market Share by Type (2016-2027)
Figure 23. North America Hysterectomy Alternatives Market Share by Application (2016-2027)
Figure 24. North America Hysterectomy Alternatives Market Share by Country (2016-2027)
Figure 25. United States Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hysterectomy Alternatives Market Share by Type (2016-2027)
Figure 29. Europe Hysterectomy Alternatives Market Share by Application (2016-2027)
Figure 30. Europe Hysterectomy Alternatives Market Share by Country (2016-2027)
Figure 31. Germany Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hysterectomy Alternatives Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Hysterectomy Alternatives Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Hysterectomy Alternatives Market Share by Region (2016-2027)
Figure 41. China Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hysterectomy Alternatives Market Share by Type (2016-2027)
Figure 49. Latin America Hysterectomy Alternatives Market Share by Application (2016-2027)
Figure 50. Latin America Hysterectomy Alternatives Market Share by Country (2016-2027)
Figure 51. Mexico Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hysterectomy Alternatives Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Hysterectomy Alternatives Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Hysterectomy Alternatives Market Share by Country (2016-2027)
Figure 57. Turkey Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Hysterectomy Alternatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Conceptus Inc. Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 61. Johnson & Johnson(Ethicon Inc.) Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 62. Hologic Inc. Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 63. Boston Scientific Corporation Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 64. Karl Storz SE & Co. KG Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 65. Cooper Companies, Inc.(Coopersurgical Inc.) Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 66. Planmeca (PLANMED OY) Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 67. Agfa-Gevaert Group Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 68. Gynecare Revenue Growth Rate in Hysterectomy Alternatives Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の調理用植物油代替品市場規模・現状・予測（2021年-2027年）

Global Vegetable Oil Alternatives For Cooking Market Size, Status and Forecast 2021-2027
QFJ1-3005 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、調理用植物油代替品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ココナッツオイル、フラックスシードオイル、ギー、グレープシードオイル、ヘンプオイル、オリーブオイル、ごま油、その他）、用途別市場規模（...

世界の船舶推進システム市場規模・現状・予測（2021年-2027年）

Global Ship Propulsion Systems Market Size, Status and Forecast 2021-2027
QFJ1-3653 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、船舶推進システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（電力、ハイブリッド電力、その他）、用途別市場規模（ヨット、航海、タグボート、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年）

Global Uterine Fibroids Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5006 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、子宮筋腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（子宮内膜アブレーション、MRIガイド処理、子宮摘出術、筋腫核出術、子宮動脈塞栓術、ラジオ波焼灼術、その他）、用途別市場規模（病院、外科医院、...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年） Uterine fibroids are frequently found incidentally during a routine pelvic exam. There's no single best approach to uterine fibroid treatment — many treatment options exist. Market Analysis and Insights: Global Uterine Fibroids Treatment Market The global Uterine Fibroids Treatment market size is pr…
世界の調理用植物油代替品市場規模・現状・予測（2021年-2027年） Cooking oils are essential for making stir-frys for dinner and salad dressings for lunch. But not all oils are the same. Some oils contain high levels of saturated fats (yes, the bad kind) and other unhealthy fats that raise cholesterol levels. These "bad" oils can also increase the risk of heart di…
世界の腫瘍塞栓市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Embolization Market The global Tumor Embolization market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes…
世界の筋腫摘出市場規模・現状・予測（2021年-2027年） Myomectomy a surgical procedure for the removal uterine fibroids. Uterine fibroids are common noncancerous growth in the uterus of women at their child bearing age, causing symptoms such as heavy bleeding during menstrual cycle, increased menstrual cramping, pain in pelvis or lower back, and swellin…
世界の子宮疾患治療薬市場規模・現状・予測（2021年-2027年） Uterus is the muscle organ in female reproductive system, which plays a great role in female reproduction and fetal development. The incidence of uterine diseases is also very high, so the treatment of uterine diseases is particularly important. Market Analysis and Insights: Global Uterine Diseases …